Results 181 to 190 of about 400,342 (335)

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

Hepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou, Yongkun Sun, Wen Zhang, Jiajia Yuan, Zhi Peng, Wei Wang, Jifang Gong, Lin Yang, Yanshuo Cao, Hong Zhao, Chao Chen, Weifeng Wang, Lin Shen, Aiping Zhou   +13 more
wiley   +1 more source

Bacterial infection is frequent in human hepatocellular carcinoma (HCC), but not in liver cirrhosis

, 2000
Karin Agha‐Amiri, Sabine M. Klauck, Peter Malfertheineer   +2 more
openalex   +1 more source

Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma

Hepatology, EarlyView., 2022
Steatotic HCC can be diagnosed by MRI and forms a pro‐tumor immune microenvironment with high expression of PD‐L1, M2 polarization of macrophages and activation of CAFs, which may be a good target for combined immunotherapy. Abstract Background and Aims Immunotherapy has become the standard‐of‐care treatment for hepatocellular carcinoma (HCC), but its ...
Hiroki Murai, Takahiro Kodama, Kazuki Maesaka, Shoichiro Tange, Daisuke Motooka, Yutaka Suzuki, Yasuyuki Shigematsu, Kentaro Inamura, Yoshihiro Mise, Akio Saiura, Yoshihiro Ono, Yu Takahashi, Yota Kawasaki, Satoshi Iino, Shogo Kobayashi, Masashi Idogawa, Takashi Tokino, Tomomi Hashidate‐Yoshida, Hideo Shindou, Masanori Miyazaki, Yasuharu Imai, Satoshi Tanaka, Eiji Mita, Kazuyoshi Ohkawa, Hayato Hikita, Ryotaro Sakamori, Tomohide Tatsumi, Hidetoshi Eguchi, Eiichi Morii, Tetsuo Takehara   +29 more
wiley   +1 more source

Serum Proteomic Profile Based on the TGF-β Pathway Stratifies Risk of Hepatocellular Carcinoma. [PDF]

Liver Int
Xiang X, Shetty K, Yu H, Mishra B, Wong LL, Zhou XJ, Satapathy SK, Crawford JM, Latham PS, Han SH, Mathew B, Dagher NN, Lau L, Cacaj F, Vegesna AK, Dasarathy S, He AR, Huang H, Amdur RL, Mishra L.   +19 more
europepmc   +1 more source

Indication and Placement of Microwave Coagulation Therapy (MCT) for the patient with hepatocellular carcinoma (HCC)

, 2000
渡久山 哲男, Shigehiro Kokubu, 高田 雅博, 山岡 佐世, Masaaki Watanabe, 日高 央, 中沢 貴秀, 渋谷 明隆, 西元寺 克禮   +8 more
openalex   +2 more sources

Development of Efficient Catalyst Layers for Proton Exchange Membrane Water Electrolysis: The Role of Catalyst Supports

Advanced Energy Materials, EarlyView.
This review highlights recent advancements in catalyst supports for the oxygen evolution reaction (OER) in proton exchange membrane water electrolysis (PEMWE), emphasizing their critical role in constructing efficient catalyst layers. It comprehensively examines support materials based on four key criteria—surface area, corrosion resistance, electrical
Yoonsu Park, Daekyu Kim, Segeun Jang, Sung Jong Yoo, Myeong‐Geun Kim   +4 more
wiley   +1 more source

IL‐31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH

Hepatology, EarlyView., 2022
IL‐31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases Abstract Background and Aims Pruritus is associated with multiple liver diseases, particularly those with cholestasis, but the mechanism remains incompletely understood.
Jun Xu, Ya Wang, Mina Khoshdeli, Matt Peach, Jen‐Chieh Chuang, Julie Lin, Wen‐Wei Tsai, Sangeetha Mahadevan, Wesley Minto, Lauri Diehl, Ruchi Gupta, Michael Trauner, Keyur Patel, Mazen Noureddin, Kris V. Kowdley, Aliya Gulamhusein, Christopher L. Bowlus, Ryan S. Huss, Robert P. Myers, Chuhan Chung, Andrew N. Billin   +20 more
wiley   +1 more source

Deep learning–assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver

European Radiology, 2021
Paula M Oestmann, Clinton J. Wang, L. Savic, C. A. Hamm, S. Stark, I. Schobert, B. Gebauer, T. Schlachter, Mingde Lin, J. Weinreb, R. Batra, D. Mulligan, Xuchen Zhang, J. Duncan, J. Chapiro   +14 more
semanticscholar   +1 more source

Evaluating the GALAD Score for Detection of Hepatocellular Carcinoma in Patients With Cirrhosis. [PDF]

J Clin Gastroenterol
Vo TD, Mai SH, Lam HT.
europepmc   +1 more source

Prognostic Impact of Hepatectomy Versus Radiofrequency Ablation for Non‐Small Hepatocellular Carcinoma (2–3 cm): A Case‐Matched Study

Annals of Gastroenterological Surgery, EarlyView.
This study aims to elucidate prognostic outcomes of hepatectomy versus RFA for primary 2–3 cm HCC. Hepatectomy may offer superior prognostic benefits, especially in those with elevated AFP levels. The local recurrence rate in hepatectomy is significantly lower than RFA.
Yuki Kitano, Hiromitsu Hayashi, Takumi Tanizaki, Yoshiyuki Tagayasu, Takashi Matsumoto, Rumi Itoyama, Shigeki Nakagawa, Hirohisa Okabe, Masaaki Iwatsuki   +8 more
wiley   +1 more source